Lobbyist Public Search

Records prior to registration year 2005 are not available online. Contact the Lobbyist Division here for assistance.	Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
	Your comments are welcome: submit feedback

Disclosure reporting details

Back to search detail summary

Lobbyist disclosure reporting period: 01/01/2020 - 06/30/2020

Lobbyist name	Robert K Coughlin
Business name	Massachusetts Biotechnology Council
Address	300 Technology Square 8th Floor
City, state, zip code	Cambridge, MA 02139
Country	USA
Agent type	Both
Phone	617-674-5100

Operating Expenses

No operating expenses were filed for this disclosure reporting period.

Activities, Bill Numbers and Titles

Client: Massachusetts Biotechnology Council

Total amount paid by client; lobbyist is unable to report compensation at activity level: $40,000.00

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
House Bill	916	An Act relative to co-pay assistance	Support	$0.00	n/a
House Bill	1168	An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth	Neutral	$0.00	n/a
House Bill	988	An Act relative to ensuring treatment for genetic craniofacial conditions	Support	$0.00	n//a
House Bill	4565	An Act relative to room and board costs for au pairs	Support	$0.00	n/a
Senate Bill	159	An Act to protect innovation and entrepreneurship in the Commonwealth	Support	$0.00	n/a
Senate Bill	706	An Act to ensure prescription drug cost transparency and affordability	Oppose	$0.00	n/a
Senate Bill	1879	An Act to ensure more women serve on corporate boards of directors	Neutral	$0.00	n/a
Executive	Massachusetts Health Policy Commission (HPC)	Monitoring Health Policy Commission implementation 958 CMR 12.00, Drug Pricing	Neutral	$0.00	n/a
House Bill	1088	An Act relative to prescription drug access	Support	$0.00	n/a
House Bill	1934	An Act to create a Massachusetts rare disease advisory council	Neutral	$0.00	n/a
House Bill	2	Governor's FY 2021 Budget Recommendations	Neutral	$0.00	n/a
Executive	Office of the Governor	Monitoring Executive Order Number 591 - Declaration of a State of Emergency to Respond to COVID-19	Neutral	$0.00	n/a
Senate Bill	640	An Act to ensure access to generic medications	Neutral	$0.00	n/a
Senate Bill	1218	An Act relative to sharps stewardship	Oppose	$0.00	n/a
Senate Bill	2484	An Act to protect innovation and entrepreneurship in the Commonwealth	Support	$0.00	n/a
House Bill	1111	An Act allowing for retail pharmacy discounts and co-pay assistance	Support	$0.00	n/a
House Bill	1972	An Act to permit the wholesale importation of prescription drugs into the Commonwealth	Oppose	$0.00	n/a
House Bill	2836	An Act re-powering Massachusetts with 100 percent renewable energy	Support	$0.00	n/a
Executive	Executive Office of Health and Human Services (EOHHS)	Monitoring DPH Bulletin Number 21 - Removal of Prior Authorization on Certain Therapeutic Classes; Utilization Management Related to COVID-19, Relaxing referral and prior approval requirements and procedures-updated-covera ge-and-payment-policies	Neutral	$0.00	n/a
Senate Bill	646	An Act to strengthen pharmacy benefit management	Neutral	$0.00	n/a
Senate Bill	1230	An Act to protect children, families, and firefighters from harmful flame retardants	Support	$0.00	n/a
Senate Bill	2598	An Act Authorizing Waiver of the One Week Waiting Period for Unemployment Benefits	Support	$0.00	n/a
House Bill	1133	An Act to ensure prescription drug cost transparency and affordability	Oppose	$0.00	n/a
House Bill	2666	An Act designating the last day of February as rare disease day in the Commonwealth	Neutral	$0.00	n/a
House Bill	4506	An Act authorizing and accelerating transportation investment	Support	$0.00	n/a
Executive	Executive Office of Health and Human Services (EOHHS)	Monitoring DPH Bulletin Number 22 - Removal of Prior Authorization on Certain Therapeutic Classes; Utilization Management Related to COVID-19, Relaxing referral and prior approval requirements and procedures-updated-covera ge-and-payment-policies	Neutral	$0.00	n/a
Senate Bill	652	An Act relative to pharmaceutical "gag clauses"	Support	$0.00	n/a
Senate Bill	1235	An Act relative to step therapy and patient safety	Support	$0.00	n/a
Senate Bill	2618	An Act providing additional support to those affected by the novel coronavirus through the unemployment insurance system	Support	$0.00	n/a
House Bill	959	An Act requiring continual coverage of prescription medication	Neutral	$0.00	n/a
House Bill	1186	An Act strengthening HPC and CHIA market oversight	Neutral	$0.00	n/a
House Bill	1050	An Act relative to ensuring treatment for genetic craniofacial conditions	Support	$0.00	n/a
Executive	Office of the Governor	Monitoring Executive Order Number 13 - Designates certain COVID Essential Services temporarily closed the brick and mortar premises of businesses and organizations that do not provide COVID-19 Essential Services, and prohibited gatherings of more than 10 people	Neutral	$0.00	n/a
Senate Bill	543	An Act reducing health care costs through improved medication management	Support	$0.00	n/a
Senate Bill	715	An Act relative to pharmaceutical price transparency and cost sharing	Neutral	$0.00	n/a
Senate Bill	563	An Act relative to ensuring treatment for genetic craniofacial conditions	Support	$0.00	n/a
House Bill	629	An Act relative to pharmaceutical pricing	Oppose	$0.00	n/a
House Bill	1162	An Act to promote transparency in prescription drug prices	Oppose	$0.00	n/a
House Bill	3654	An Act relative to compensation for victims of opioids	Neutral	$0.00	n/a
House Bill	4547	An Act authorizing and accelerating transportation investment	Support	$0.00	n/a
Senate Bill	120	An Act relative to consumer data privacy	Neutral	$0.00	n/a
Senate Bill	696	An Act to promote transparency and cost control of pharmaceutical drug prices	Oppose	$0.00	n/a
Senate Bill	1701	An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing	Oppose	$0.00	n/a
Senate Bill	2769	An Act Putting Patients First	Neutral	$0.00	n/a
House Bill	1062	An Act relative to transparent health care data	Neutral	$0.00	n/a
House Bill	1930	An Act providing for unused medication return by health care facilities	Neutral	$0.00	n/a
House Bill	4268	An Act to create a Massachusetts rare disease advisory council	Neutral	$0.00	n/a
Executive	Office of the Governor	Monitoring Executive Order Number 35 - Clarifies the progression of the Commonwealth’s Phased Workplace Re-Opening Plan and Authorizing certain re-opening preparations at Phase II workplaces	Neutral	$0.00	n/a
Senate Bill	611	An Act to promote value-based insurance design in the Commonwealth	Oppose	$0.00	n/a
Senate Bill	1206	An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth	Support	$0.00	n/a
Senate Bill	2433	An Act relative to step therapy and patient safety	Support	$0.00	n/a
House Bill	949	An Act relative to non-medical switching	Support	$0.00	n/a
House Bill	1178	An Act relative to promoting transparency in the pharmaceutical industry	Support	$0.00	n/a
House Bill	1036	An Act relative to ensuring treatment for genetic craniofacial conditions	Support	$0.00	n/a
House Bill	4806	Governor's Interim Spending Budget for FY2021	Neutral	$0.00	n/a
Senate Bill	541	An Act relative to co-pay assistance	Support	$0.00	n/a
Senate Bill	712	An Act to promote transparency and prevent price gouging of pharmaceutical drug prices	Oppose	$0.00	n/a
Senate Docket	2264	An Act to create a Massachusetts rare disease advisory council	Neutral	$0.00	n/a
Executive	Executive Office of Health and Human Services (EOHHS)	Monitoring Executive Office of Health & Human Services implementation 101 CMR 801.00: Drug Manufacturer Negotiations and Accountability	Neutral	$0.00	n/a
House Bill	966	An Act to promote value-based insurance design in the Commonwealth	Oppose	$0.00	n/a
House Bill	1192	An Act relative to the examination of health care cost trends in MassHealth	Neutral	$0.00	n/a
House Bill	1116	An Act relative to ensuring treatment for genetic craniofacial conditions	Support	$0.00	n/a
Executive	Office of the Governor	Monitoring Executive Order Number 21 - Extends the period in which COVID-19 Order No. 13 would continue to restrict the operation of businesses and organizations that do not provide COVID-19 Essential Services	Neutral	$0.00	n/a
Senate Bill	552	An Act to promote transparency in prescription drug prices	Oppose	$0.00	n/a
Senate Bill	721	An Act relative to mandatory prescription drug coverage	Oppose	$0.00	n/a
Executive	Massachusetts Health Policy Commission (HPC)	Monitoring the Health Policy Commission implementation of Chapter 363 of the Acts of 2018, An Act Extending the Authorization for the use of certain discount vouchers for prescription drugs	Neutral	$0.00	n/a
House Bill	1148	An Act regarding Massachusetts drug price relief	Oppose	$0.00	n/a
House Bill	3481	An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth	Support	$0.00	n/a
House Bill	4508	An Act relative to transportation finance	Support	$0.00	n/a
Executive	Executive Office of Health and Human Services (EOHHS)	Monitoring MassHealth Bulletin Number 289 - MassHealth Coverage and Reimbursement Policy for Services Related to COVID-19	Neutral	$0.00	n/a
Senate Bill	653	An Act relative to prescription drug pricing	Neutral	$0.00	n/a
Senate Bill	1295	An Act to reduce healthcare costs by promoting non-biased prescriber education	Oppose	$0.00	n/a
Senate Bill	2671	An Act to reduce healthcare costs by promoting non-biased prescriber education	Oppose	$0.00	n/a
House Bill	1055	An Act to ensure access to generic medications	Neutral	$0.00	n/a
House Bill	1860	An Act relative to the dispensing of prescription drugs	Neutral	$0.00	n/a
House Bill	4228	An Act relative to fail first and patient safety	Support	$0.00	n/a
Executive	Office of the Governor	Monitoring Executive Order Number 33 - Authorizes the re-opening of certain brick-and-mortar premises designated as Phase I workplace	Neutral	$0.00	n/a
Senate Bill	601	An Act to reduce the cost of pharmacy benefits	Neutral	$0.00	n/a
Senate Bill	1149	An Act strengthening prescription drug safety and drug stewardship	Oppose	$0.00	n/a
Senate Bill	2409	An Act relative to pharmaceutical access, costs and transparency	Oppose	$0.00	n/a
House Bill	1013	An Act relative to pharmaceutical gag clauses	Support	$0.00	n/a
House Bill	1193	An Act providing for the establishment of a drug cost review commission	Neutral	$0.00	n/a
House Bill	4134	An Act to improve health care by investing in VALUE	Neutral	$0.00	n/a
Executive	Office of the Governor	Monitoring Executive Order Number 30 - Extends the period in which COVID-19 Order No. 13 would continue to restrict the operation of businesses and organizations that do not provide COVID-19 Essential Services	Neutral	$0.00	n/a
Senate Bill	570	An Act relative to out-of-pocket expenses for prescription drug coverage	Support	$0.00	n/a
Senate Bill	728	An Act providing affordable access to generic medicines	Neutral	$0.00	n/a
Senate Bill	2338	An Act to protect children, families, and firefighters from harmful flame retardants	Support	$0.00	n/a
House Bill	1016	An Act establishing a commission to study maximum allowable costs lists	Neutral	$0.00	n/a
House Bill	1853	An Act relative to fail first and patient safety	Support	$0.00	n/a
House Bill	4211	An Act to improve patient access to cancer clinical trial programs	Support	$0.00	n/a
Executive	Office of the Governor	Monitoring Executive Order Number 32 - Extends the period in which COVID-19 Order No. 13 would continue to restrict the operation of businesses and organizations that do not provide COVID-19 Essential Services	Neutral	$0.00	n/a
Senate Bill	582	An Act ensuring access to medications	Neutral	$0.00	n/a
Senate Bill	733	An Act relative to consumer protection for prescription drug purchases	Support	$0.00	n/a
Senate Bill	2397	An act relative to Pharmaceutical Access, Costs and Transparency	Oppose	$0.00	n/a
House Bill	229	An Act to protect innovation and entrepreneurship in the Commonwealth	Support	$0.00	n/a
House Bill	1154	An Act to reduce drug costs through transparency	Oppose	$0.00	n/a
House Bill	3500	An Act to protect children, families, and firefighters from harmful flame retardants	Support	$0.00	n/a
House Bill	4529	An Act enabling partnerships for growth	Support	$0.00	n/a
Executive	Executive Office of Health and Human Services (EOHHS)	Monitoring MassHealth Bulletin Number 291 - MassHealth Coverage and Reimbursement Policy for Services Related to COVID-19	Neutral	$0.00	n/a
Senate Bill	654	An Act to strengthen pharmacy benefit management	Neutral	$0.00	n/a
Senate Bill	1301	An Act to prevent undue influence on prescriber behavior	Oppose	$0.00	n/a
Senate Bill	2739	An act Authorizing and Accelerating Transportation Investment (Recommended new text of H4547)	Support	$0.00	n/a
House Bill	391	An Act relative to reprogrammed human skin cells for embryonic stem cell research	Neutral	$0.00	n/a
House Bill	1660	An Act promoting pay transparency and pipeline advancement	Neutral	$0.00	n/a
House Bill	3551	An Act to promote transparency and cost control of pharmaceutical drug prices	Oppose	$0.00	n/a
House Bill	4530	An Act relative to transportation finance	Support	$0.00	n/a
Executive	Department of Public Health (DPH)	Monitoring the Department of Public Health emergency order regarding modifications to pharmacy practice	Neutral	$0.00	n/a
Senate Bill	695	An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern	Oppose	$0.00	n/a
Senate Bill	1304	An Act to restore integrity in the marketing of pharmaceutical products and medical devices	Oppose	$0.00	n/a
Senate Bill	2746	An Act financing improvements to municipal roads and bridges	Support	$0.00	n/a
House Bill	915	An Act ensuring access to medications	Neutral	$0.00	n/a
House Bill	1167	An Act relative to prescription drug price transparency	Oppose	$0.00	n/a
House Bill	3877	An Act relative to capping the price of life saving prescription drugs	Oppose	$0.00	n/a
House Bill	4567	An Act relative to the application of the Domestic Workers Bill of Rights as it pertains to Au Pairs	Support	$0.00	n/a
Senate Bill	154	An Act relative to bad faith assertions of patent infringement	Support	$0.00	n/a
Senate Bill	703	An Act to define modest meals and refreshments in prescriber education settings	Oppose	$0.00	n/a
Senate Bill	1780	An Act relative to repealing the Employer Medical Assistance Contribution Supplement Tax	Neutral	$0.00	n/a
Senate Bill	2796	An Act Putting Patients First (Printed-as-amended version of SB2769)	Neutral	$0.00	n/a
			Total amount	$0.00

Meals, Travel, and Entertainment Expenses

No meals, travel, or entertainment expenses were filed for this disclosure reporting period.

Additional Expenses

No additional expenses were filed for this disclosure reporting period.

Campaign Contributions

Date	Recipient name	Office sought	Amount
02/12/2020	John Lawn	State Representative, 10th Middlesex District	$200.00
05/13/2020	James Coughlin	Norfolk County Sherriff	$200.00
05/18/2020	Rob Consalvo	State Representative, 14th Suffolk District	$200.00
		Total contributions	$600.00

Close this page

Connect with Us